GDF2 and pulmonary arterial hypertension: However, inhibiting BMP9 to limit its impact on pulmonary hypertension has shown beneficial effects in pre-clinical animal models of PAH [30] and Paul Yu’s lab recently described in an abstract that BMP9 contributes to experimental PH by regulating expression of EC-derived molecules modulating PASMC growth and phenotype [32].